Pathological changes in excitability of cortical tissue commonly underlie the initiation and spread of seizure activity in patients suffering from epilepsy. Accordingly, monitoring excitability and controlling its degree using antiepileptic drugs (AEDs) is of prime importance for clinical care and treatment. To date, adequate measures of excitability and action of AEDs have been difficult to identify. Recent insights into ongoing cortical activity have identified global levels of phase synchronization as measures that characterize normal levels of excitability and quantify any deviation therefrom. Here, we explore the usefulness of these intrinsic measures to quantify cortical excitability in humans. First, we observe a correlation of such markers with stimulation-evoked responses suggesting them to be viable excitability measures based on ongoing activity. Second, we report a significant covariation with the level of AED load and a wake-dependent modulation. Our results indicate that excitability in epileptic networks is effectively reduced by AEDs and suggest the proposed markers as useful candidates to quantify excitability in routine clinical conditions overcoming the limitations of electrical or magnetic stimulation. The wake-dependent time course of these metrics suggests a homeostatic role of sleep, to rebalance cortical excitability.
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excitability | epilepsy | sleep N ormal functioning of cortical networks critically depends on a finely tuned level of excitability, the transient or steady-state response in which the brain reacts to a stimulus. Whereas small, local responses indicate a comparably small excitability, large and global responses consequently suggest excitability to be high. The importance of adequate excitability levels is highlighted by the pathological consequences and impaired performance resulting from aberrant network excitability. In epilepsy, changes in cortical network excitability are believed to be an important cause underlying the initiation and spread of seizures, that is, the large nonphysiological neuronal activity events across time and space (1) (2) (3) . Evidence for changes of excitability in brain networks affected in epilepsy has come from a variety of observations. To assess the level of excitability under in vivo experimental conditions one usually measures the size of the evoked cortical activity to external perturbations, typically either by transcranial magnetic stimulation (TMS) or, in the case of epilepsy patients, by electrical stimulation. Studies of electrical stimulation with subdural electrodes during interictal periods found the evoked potentials to be larger in regions related to the cortical onset region of epileptiform activity (4) (5) (6) . The enhanced responses to electrical stimulation in epileptogenic cortex were taken as indication of an increased excitability of neural tissue in these areas. Similarly, studies using TMS consistently reported a hyperexcitability in focal epilepsies (7) (8) (9) (10) . Consequently, changes in excitability have been helpful in identifying the seizure focus before resective surgery. The insight that epilepsy is related to hyperexcitability is also at the basis of pharmacological treatment options for patients. Most antiepileptic drugs (AEDs) aim to reduce the excitability in neural tissue by reducing the excitability of individual neurons through selective ion channel blockers, enhancing inhibitory synaptic transmission or inhibiting excitatory synaptic transmission (11) . Robust markers of excitability could therefore potentially be useful to guide the treatment with AEDs by giving feedback of their effect and efficiency on epileptic networks.
Apart from aberrant pathological deviations, changes in cortical excitability are believed to play a role in normal conditions during the course of wake and sleep. A perturbational approach to study excitability in human cortex found increased responses after a period of sustained wakefulness that were rebalanced after sleep (12, 13) . Such findings suggest that excitability could increase during wake, which might result in suboptimal information processing in cortical networks (14, 15) and point to a pivotal role of sleep in rebalancing the level of excitability. However, a continuous measurement of excitability during the wake/sleep cycle supporting this hypothesis is hard to obtain with current measures.
A thorough understanding of excitability and how to monitor it in brain networks is therefore highly desirable for an understanding of both normal as well as pathological brain function. Cortical excitability is generally a product of both excitation and inhibition in a network. Changes in excitability can consequently Significance Dynamic changes of cortical excitability are relevant in both healthy and pathological network dynamics. In epilepsy, pathological changes in excitability commonly underlie the initiation and spread of seizures. Accordingly, the ability to monitor excitability and control its degree is important for adequate clinical care and treatment because classic EEG markers found in epilepsy such as interictal spikes do not reflect seizure propensity and thus excitability. Here, we identify excitability markers and test them on long-term electrocorticogram and EEG recordings. We show that they correlate with more direct excitability measures using external stimulation and allow for real-time excitability monitoring. Our results provide evidence that excitability of cortical networks is reduced by antiepileptic drugs and increases as a function of time awake.
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This article is a PNAS Direct Submission. arise from changes in excitation and/or changes in inhibition. To date, most approaches to quantify excitability have focused on perturbational approaches by electrical or magnetic stimulation where evoked responses to a brief electrical or magnetic stimulation are plotted over time (5, 6, 16, 17) . A disadvantage of these methods, however, is their complex design, which limits regular clinical use and continued monitoring of the time course over extended periods of time. Even more so, the fact that such perturbations can induce seizures constitutes a considerable limitation for its application in patients suffering from epilepsy (18) . For these various reasons, intrinsic excitability measures (IEMs) based on ongoing activity without the need of external perturbations would be preferable and likely to provide novel insights because of a broader applicability due to their noninvasive nature.
Recent insights into cortical activity from computational modeling (19, 20) , experiments in cultures in vitro (21) , rodents (22, 23) , and also human magnetoencephalography and EEG (14, 24) have pointed to the ability of global synchronization measures to characterize physiological cortical dynamics. It was shown that phase synchronization of ongoing cortical activity exhibits moderate mean over a broad range of frequency bands under normal conditions. The ability to pharmacologically control the excitation/inhibition (E/I) axis in cortical in vitro preparations and rodents in vivo revealed the E/I level to be a crucial parameter affecting cortex activity to which synchronization markers are sensitive. Specifically, the E/I balance or ratio can be modulated toward a more inhibited system by selectively blocking excitatory glutamatergic synaptic transmission. Conversely, inhibition can be reduced by pharmacological application of inhibitory gabaergic synaptic transmission blockers, leading to an overall disinhibited state. Experimental approaches in which the E/I axis was altered in this way have shown that networks, which transition from inhibited to normal to disinhibited states by pharmacological manipulation, exhibit spontaneous dynamics characterized by a progressive increase in phase synchronization and a peak in its variability at normal, unchanged E/I levels. These synchronization changes have been shown to occur between cell assemblies measured by microelectrode arrays and can be observed over a broad frequency range (21) . The distinct changes from cell assemblies in vitro and in rodents suggest global synchronization measures to be potentially valuable IEMs in human cortical networks.
Here, we explore the use of IEMs as a method to monitor excitability in clinical settings. To this end we first compare intrinsic measures to more direct measures of excitability using a perturbational approach. Second, we analyze large-scale invasive EEG (iEEG) datasets obtained during presurgical monitoring of epilepsy patients as well as scalp EEG data of healthy participants during sustained wakefulness. During the multiday, continuous iEEG recordings, AEDs were typically tapered off to increase the likelihood for epileptic seizures and identify their onset zones (25) . These datasets are therefore ideally suited to study electrophysiological markers of excitability in clinical settings under changing levels of E/I balance due to variations in AED dosage.
Results
In light of the characteristic changes observed in cortical cultures in vitro and rodents in vivo, we focused on the mean of phase synchronization dynamics as a potential IEM in cortex in humans. Specifically, we hypothesized that the mean levels of phase synchronization should positively correlate with cortical excitability. To evaluate whether such a direct correlation exists we probed cortical excitability in human electrocorticogram (ECoG) by electrical stimulation. Previous work has shown that the amplitude of evoked cortical potentials by short pulses of electrical stimulation is a direct measure of cortical excitability: Whereas small amplitudes indicate a comparably small excitability, large responses suggest excitability to be high (5, 6, 26) . We designed a stimulation protocol that allowed us to measure electrical stimulation-evoked responses as a direct marker of excitability, as well as phase synchronization of ongoing activity as a potential IEM over long periods of time within individual patients. Fig. 1A shows a typical evoked response in one channel. The amplitude A of evoked potentials, measured from highest peak to lowest trough, exhibited considerable variation (Fig. 1B) , indicating varying levels of excitability over the course of hours. Unperturbed time segments before each stimulus (Fig. 1A , gray bar) were used to calculate phase synchronization in different frequency bands. We observed that mean synchronization levels R followed a very similar time course (Fig. 1B ) that was reflected in high correlation values between amplitude A and synchronization R (Fig. 1C ). This significant correlation was observed across a broad range of frequencies from 50 to 400 Hz and in n = 2 patients under investigation (Fig. 1D) . Throughout the paper, we will focus on IEM in this frequency range (i.e., the bands 50-100 Hz, 100-200 Hz, and 200-400 Hz). Conversely, absolute power averaged over all channels in these frequency bands did not exhibit a positive correlation with stimulation-evoked responses ( Fig. S1 A and C). These results provide an indication that mean levels of phase synchronization are related to cortical excitability in humans and consequently suggest them as valid indicators of excitability based on ongoing cortical activity.
Next, we analyzed invasive EEG from 10 patients undergoing presurgical monitoring during which antiepileptic medication had been varied. No stimulation was performed in these patients. The type of AEDs used during this time, their dosages, and the time course by which they were tapered off were solely determined by clinical considerations and varied between patients. We were interested whether synchronization measures would, analogously to in vitro analyses under pharmacological manipulation, exhibit an AED-dependent trajectory that would be consistent with the hypothesis of a change in E/I balance. We thereby focused particularly on mean levels of synchronization R in the frequency range of 50-100 Hz because stimulation analysis had revealed a good correlation with evoked responses in this frequency band and because this frequency range could also be resolved in datasets recorded with lower sampling rates. In the following we will therefore use R 50−100Hz as the primary IEM, although results were generally robust over a broader range of frequencies ( Fig. S2 and see Fig. 3 ). Mean synchronization R exhibited considerable variability during the multiday recordings in each patient. Fig. 2A shows time courses for four representative patients. Typically, R was low during days with high AED load and increased when AEDs were reduced. The time course of R thereby closely followed an inverse relation with AED load. Because especially the highest R values showed a strong dependence on AED, we averaged over each day's highest 12 h to determine a daily mean ( Fig. 2A, solid bars) . Absolute signal power in these frequency bands did not, similar to stimulation results, correlate as well with AED load (Fig. S1 B and D) . To quantify the visually observed dependence of R on AED dosage ( Fig. 2A) , we compared R values from one day of highest AED load (high AED) to the day with the lowest dose of AED (low AED) in each patient. The day with high AED load was usually the first full day of recording. When there was more than 1 d with the same amount of low or no AED, we chose the one furthest away from the high-AED day. Statistical analysis revealed a significant increase in R from high to low levels of AED for the majority of patients (Fig. 2B, two-sided paired sample t test) .
As a test whether the observed changes in R were only driven by a subset of channels we repeated the synchronization analysis for channels in the seizure onset zone only as well as for the channels outside the seizure onset zone. As channels that were part of the seizure onset zone we considered those that had been defined by an experienced epileptologist as channels from which at least one seizure had originated. The remaining channels were consequently defined as those outside of the seizure onset zone. Fig. S3 shows results from two representative patients; the AED-dependent changes in R are similarly observed in networks encompassing all channels, only channels of the seizure onset zone, and only channels outside the seizure onset zone. Our results are therefore consistent with the hypothesis that AEDs reduce the E/I balance and decrease excitability in widespread cortical networks.
To gain better insight into the function of AEDs on network dynamics, we separated days on which no AED had been given from days where AED had been applied. We observed that cortical network activity without AED typically settled at R levels in the vicinity of R ' 0.5 (Fig. 3A, black bars in histogram) . Previous in vitro studies had suggested that normal cortical dynamics under a physiological E/I balance is, besides moderate levels of the mean, characterized by a maximum in variability of synchronization (21) . In our case, we observed that peak variability H was found at R ' 0.5 (Fig. 3A, gray circles) . For a measure like R bounded between [0,1] a peak variability occurring near R ' 0.5 is not surprising because any fluctuations will be increasingly cut off the closer the mean gets to either of the boundaries, resulting in decreases of variability there. During times when AEDs had been administered, we observed that markedly more time was spent at lower R values, as is evident by the left shift visible in the histogram (Fig. 3A , blue bars in histogram). Comparison between "no AED" and "AED" hours revealed a significant decrease from R ' 0.5 to lower values across a broad range of frequencies along with a drop in variability H (Fig. 3B , two-sided independent sample t test). Fig. 3C schematically summarizes the qualitative behavior of IEMs as a function of the ratio of excitation and inhibition (E/I) or, more generally, network excitability as observed in our data. As excitability is pharmacologically increased from disfacilitated to disinhibited dynamics, R increases. In our data we observed an increase of R when AED load was reduced. This is in line with observations in cortex cultures and provides strong indication for an increase in excitability in cortical networks when AEDs are tapered off. These analogies suggest that excitability is effectively reduced by AEDs (Fig. 3C, blue arrow) and, together with the correlation to stimulation-evoked responses reported above, provide further support for R as a measure of cortical excitability. An advantage of excitability measures based on ongoing activity such as R is their ability to be used for continuous monitoring over extended periods of time. In the following we will further explore how this continual measurement can uncover insights into the modulation of excitability.
Apart from the dependency on AED load, we observed that R exhibited considerable variability within a day ( Fig. 2A, gray  markers) . To further investigate these modulations we averaged the daily time course of all 10 subjects and over all 70 d. Values of R showed a characteristic modulation over the course of a day: an increase and high levels from morning to evening hours followed by a decrease and low levels during the night (Fig. 4A and Fig. S4 ). The increase from morning hours (hours 5-7) to evening hours (hours 17-19) was significant over a broad frequency range (Fig. 4B , two-sided paired sample t test) and could suggest distinct changes in cortical excitability over the 24-h time course. Because, on average, patients were more likely to be awake during daytime hours and more likely to sleep during nighttime hours, we hypothesized that this modulation of R could be related to changing levels of vigilance and be a function of time awake. Although the average sleep pattern of patients provides some indication for such a vigilance-dependent modulation, further proof is needed because a rigorous control of vigilance across time for all patients was not feasible in a clinical setting. To further investigate the relationship between R and vigilance we therefore extended our analysis to a dataset of eight healthy subjects where vigilance had been rigorously monitored and controlled. There, scalp EEG had been recorded every 3 h over a period of 40 h of sustained wakefulness (14, 27) . During this period of wakefulness we observed an increase of R that was significantly correlated to the time awake (Fig. 4 C and D and Fig. S4 ). In light of the ability of R to closely track excitability in electrical stimulation and AED conditions, the results from invasive and noninvasive scalp EEG recordings are in line with the hypothesis of an increasing excitability as a function of time awake.
Discussion
In the present work we propose IEMs, that is, measures that quantify cortical network excitability based on intrinsic ongoing activity. The use of such IEMs is motivated by theoretical considerations suggesting cortical networks reside near a synchronization transition (19, 20) along with experimental studies illustrating their sensitivity to changes in the E/I axis in cortical in vitro preparations and rodents (21-23,) . Our main finding is that these measures correlate well with AED load in patients, which suggests that they are viable markers of cortical excitability in humans. This is further supported by their correlation with stimulation-evoked responses-the current gold standard for excitability measurements-in human subdural recordings. We uncover a characteristic modulation over 24 h in line with the hypothesis of a progressively increasing excitability during wakefulness that is rebalanced during sleep.
To date, reliable measures of cortical excitability based on ongoing activity have been difficult to obtain. In particular, classic EEG markers found in epilepsy such as interictal spikes have been shown not to reflect seizure propensity and thus excitability (28) . Instead, excitability is usually measured as the response to electrical or magnetic stimulation. Such perturbational approaches allow measurements to be well-controlled in space and time. However, the invasiveness and relative technical complexity in setup and analysis limit the practicability and its applicability for long-term and continuous monitoring. Furthermore, individual responses to perturbations will naturally exhibit a high variability due to the dependence of the induced activity on initial conditions (29) , which requires a high number of trials to converge to a robust measure. With respect to a potentially broad applicability in epilepsy patients perturbational approaches by electric pulses or TMS can be problematic due to their ability to induce seizures. IEMs as proposed in the present study naturally circumvent these problems.
One of the advantages of IEMs is their ability to passively monitor excitability over long continuous time periods; in contrast, perturbational approaches classically considered to measure excitability are limited in this regard. Consequently, the investigation of changes in human cortical excitability during the sleep-wake cycle has so far been limited to only a few measurements based on TMS responses (13) . There, increased responses as a function of time awake were found and taken as indication of an increasing cortical excitability. A TMS study on epilepsy patients, too, suggested increased excitability during sleep deprivation (12) . Similarly, a recent study using an implantable brain stimulation and sensing system in canines reported characteristic changes in excitability following a circadian profile and a dependency on AEDs (30) . The continuous iEEG measurement of IEMs over combined 70 d of 10 subjects and in sleep deprivation data reported here revealed changes in R including elevated levels in daytime hours and an increase during wake which are in line with these studies indicating an increase in excitability as a function of time awake. The combined analysis from all 70 nights investigated here also robustly showed a decrease of R during nighttime even though one of the two stimulation patients (patient 1) temporarily exhibited high values of synchronization R and evoked potential amplitude A during the night. A potential explanation for the increased stimulation responses could be the intrinsic tendency of cortical neurons to fall into a down state after a transient activation during non-rapid eye movement sleep, as recently discussed in ref. 31 . The overall steady levels of cortical stimulation markers in the long term observed here as well as in ref. 32 do not suggest stimulation itself to be the cause for an increasing excitability, in our opinion. With more datasets including both ongoing and stimulation activity becoming available it will be important to further explore the relation between A and R beyond the two patient datasets presented in this study.
The observed dependence of IEMs on time awake and sleep could indicate a close relation to the homeostatic function of sleep (33) . A current hypothesis states that synaptic homeostasis is underlying sleep homeostasis: Net synaptic strength increases during waking due to plastic processes leading to a larger excitability and decreases by means of synaptic downscaling during sleep (34, 35) . Observations of changes in synaptic strength in Drosophila (36) support the hypothesis by providing evidence of structural changes occurring during waking and their reorganization during sleep. Such changes could underlie an increase in excitability during time awake and would be in line with the interpretation of R as a measure of it. Besides a growth in net synaptic strength other mechanisms are also conceivable to govern an increase in network excitability. For example, a relative reduction of inhibition during time awake would similarly lead to an increase in the E/I balance. On a neuronal network level such structural wake-dependent alterations have been discussed to drive networks to states suboptimal for information processing (14) . Despite the possibility that increasing synchrony R indicates an increase in excitability during wake, it is also conceivable that mechanisms other than increasing excitability are underlying the observed changes in R. For example, one could speculate that the elevated likelihood of neurons to go "offline" together, as observed in sleep-deprived rats (37), could manifest itself in increased synchronization levels measured from larger-scale data such as EEG.
Although perturbational approaches to measure excitability by electrical or transcranial magnetic stimulation have proven to be a valuable research tool, they are currently unsuitable for regular clinical monitoring. It has been shown that long-term continuous monitoring can reveal important insights into seizure dynamics and its predictions (38) . For these kinds of clinical settings passive measures of excitability by IEMs are preferable. Quantitative markers of excitability can potentially guide more objective and individualized treatment approaches in epilepsy patients. Although IEMs cannot directly show changes in neuronal excitability, their change as a function of AED load reported here is consistent with the hypothesis of an effective reduction of cortical excitability by AEDs and provides a further indirect validation for IEMs besides their correlation with more direct measurements of excitability by stimulation. Synchronization R changed similarly as a function of AED load across all frequency bands investigated from 50 to 400 Hz. It is possible that these changes are to some extent correlated with the appearance of ripples or fast ripples in epilepsy patients. The similar trajectories observed within and outside the seizure onset zone as well as across frequencies, however, make a sole dependence of measure R on fast ripples less likely. A reliable biomarker of excitability stands the chance to monitor the therapeutic effectiveness of newly given AEDs. The observation of a robust value of R ' 0.5 in iEEG characterizing physiological network synchronization levels without AEDs could, if further validated, provide an absolute reference point with which drug effects on network dynamics could be compared. In scalp EEG recording analyzed here, we observed overall higher values of R (Fig. 4) , which might be due to higher volume conduction compared with ECoG. In such a case, relative changes in R within a subject could be used to monitor excitability under different conditions and time. Regarding a potential reference point of R ' 0.5, one should also keep in mind the possibility that epilepsy patients could present a slightly different R value, either a bit higher or lower than healthy subjects, even when untreated.
The moderate and similar levels of R across patients and frequency bands observed here under normal, no-AED conditions posits cortical networks to spend most of the time at the transition from low to high synchronization. Previous theoretical work has shown that self-organization to such a synchronization transition is conceivable under realistic assumptions (19, 20) and that, more generally, being positioned near a transition can support optimal information processing capabilities (39) . With respect to the use of AEDs, the markers proposed here can potentially provide a complementary tool in adjusting AED dosages to optimal levels for a successful treatment on one side and controlling adverse drug effects on the other side. This is particularly important in light of common side effects of AEDs on cognition such as cognitive slowing, sedation, somnolence, and distractibility (40) . Although it may be good for epilepsy patients to have a lower R value corresponding to a lower excitability to prevent the likelihood of seizures, the concomitant decrease in the variability of synchronization might be disadvantageous for optimal brain network functioning. Previous studies using in vitro preparations have shown that the IEMs similar to the ones used here are closely related to certain capabilities in information processing (41) (42) (43) (44) . IEMs could therefore be potential candidates to quantify the neural correlates of such cognitive deficits in humans.
Materials and Methods
Preprocessing of ECoG Data. We analyzed two datasets of ECoG data: (i) data from n = 2 patients where regularly recurring electrical stimuli had been applied over at least a day while stimulation responses as well as unperturbed activity in between stimulations had been recorded and (ii) multiday recordings of ongoing activity (i.e., without electrical stimulation) from n = 10 patients under varying levels of AEDs (see Supporting Information for details). Patients gave informed consent. Ethics approval for dataset (i) was obtained from St. Vincent's Human Research Ethics Committee.
EEG Recordings During Prolonged Wakefulness. We analyzed waking EEG recordings of eight healthy, young, right-handed males (23.0 ± 0.46 y; mean ± SEM) during 40 h of sustained wakefulness (data from a previous study; for details see ref. 27) . During this time, participants were under constant surveillance. The waking EEG was recorded in 14 sessions at 3-h intervals starting at 0700 hours. Sessions consisted of a first 5-min eyes-open period, followed by a 4-to 5-min eyes-closed period, and a second 5-min eyes-open period. Twenty-seven EEG derivations (extended 10-20 system; n = 27 electrodes; reference electrode 5% rostral to Cz) were sampled with 256 Hz (highpass filter at 0.16 Hz; anti-aliasing low-pass filter at 70 Hz). Artifacts including eye blinks were marked by visual inspection. We analyzed artifact-free segments of 4-s duration during the eyes-open condition. Each 4-s segment was filtered in the frequency band of interest (phase neutral filter by applying a second-order Butterworth filter in both directions) to derive synchrony measures.
